Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
Clinical trial NCT07040319 · RECRUITING
Trial details
- NCT number
- NCT07040319
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-25
- Primary completion
- 2028-03-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.